MedPath

Influences of antibiotics on biodiversity of intestinal microbiota in newborns

Conditions
intestinal flora
Microbiota
10017966
10004018
Registration Number
NL-OMON33555
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

Inclusion criteria Group 1
• Newborn infants born by vaginal delivery
• Without any complications during both intrauterine and intra partum period
• No antenatal/postnatal antibiotics
• Normal healthy infant
• Breastfed;Inclusion criteria Group 2
• Newborn infants born by vaginal delivery
• Without complications during both intrauterine and intra partum period except minor risk factors (GBS colonisation, unknown GBS status, Temp < 39°C) to prescribe antenatal antibiotics to the mother
• Antenatal antibiotics I.V. (2-8 hours before delivery)
• No postnatal antibiotics
• Normal healthy infant
• Breastfed;Inclusion criteria Group 3
• Newborn infants born by vaginal delivery
• Without any complications during both intrauterine and intra partum period
• No antenatal antibiotics
• Postnatal antibiotic therapy started within first 12 hours after birth and discontinued within 48-72 hours (discontinued course of antibiotics).
• Normal healthy infant with low risk for early onset sepsis
• Breastfed;Inclusion criteria Group 4
• Newborn infants born by vaginal delivery
• Without any complications during both intrauterine and intra partum period
• No antenatal antibiotics
• Postnatal antibiotic therapy started within first 12 hours after birth and discontinued after one week (full course of antibiotics).
• Normal healthy infant in whom an early onset sepsis could not be excluded.
• Breastfed;Inclusion criteria Group 5
• Newborn infants born by cesarean section
• Without any complications during both intrauterine and intra partum period
• No antenatal/postnatal antibiotics
• Normal healthy infant
• Breastfed

Exclusion Criteria

- APGAR Score after 5 minutes < 6
- Major congenital abnormality
- Congenital abnormonality of gastro intestinal tract

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Biodiversity of intestinal microbiota in newborns. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The quantity of the specific bacteria in the intestinal microbiota of the<br /><br>newborn infant. </p><br>
© Copyright 2025. All Rights Reserved by MedPath